[PDF][PDF] MicroRNA-31 reflects IL-6 expression in cancer tissue and is related with poor prognosis in cholangiocarcinoma.
K Ishigami, K Nosho, H Koide, S Kanno… - 札幌医学 …, 2019 - sapmed.repo.nii.ac.jp
Cholangiocarcinoma is a highly aggressive malignancy wherein early diagnosis is difficult
and few treatment options are available. MicroRNA-31 (miR-31) is reported to be related …
and few treatment options are available. MicroRNA-31 (miR-31) is reported to be related …
Новые патогенетические механизмы развития неалкогольной жировой болезни печени на фоне метаболического синдрома: фокус на микроРНК
ГД Фадеенко, ИЕ Кушнир, АЕ Гриднев… - Современная …, 2019 - elibrary.ru
Неалкогольная жировая болезнь печени (НАЖБП)-наиболее распространенное
заболевание печени в мире. Современный патогенез НАЖБП связывают с …
заболевание печени в мире. Современный патогенез НАЖБП связывают с …
Role of mitochondria-targeting miRNAs in non-alcoholic fatty liver disease
ADL Simão - 2019 - repositorio.ul.pt
Non-alcoholic fatty liver disease (NAFLD) comprises a range of liver lesions from simple
steatosis to non-alcoholic steatohepatitis (NASH) and remains a major cause of mortality …
steatosis to non-alcoholic steatohepatitis (NASH) and remains a major cause of mortality …
[PDF][PDF] Study of non-alcoholic steatosis in patients with type 2 diabetes mellitus in a tertiary hospital
A Patange, S Rao, P Desai, A Desai, D John… - … OF EVOLUTION OF …, 2016 - academia.edu
BACKGROUND Fatty liver disease or non-alcoholic steatosis affects a growing number of
the adult diabetic population in developed countries. The main aim of this study was to …
the adult diabetic population in developed countries. The main aim of this study was to …
[引用][C] Possibilities of using natural mineral waters in the treatment of patients with non-alcoholic fatty liver disease
S Gushcha, N Dragomiretska, I Zabolotna, B Nasibullin… - 2019